N(6)-disubstituted adenoisine compounds and therapeutic compositions
    6.
    发明授权
    N(6)-disubstituted adenoisine compounds and therapeutic compositions 失效
    N(6) - 二取代腺苷化合物和治疗组合物

    公开(公告)号:US3966916A

    公开(公告)日:1976-06-29

    申请号:US525795

    申请日:1974-11-21

    IPC分类号: C07H19/16 A61K31/70

    CPC分类号: C07H19/16

    摘要: New N(6)-disubstituted adenosine compound of the formula ##SPC1##WhereinR.sub.1 is lower alkyl substituted by at least one of hydroxyl, alkoxy or acyloxy; or is cycloalkyl or straight-chained or branched lower alkenyl;R.sub.2 and R.sub.3 are hydrogen, halogen, or nitro or lower alkyl, alkoxy or alkylthio andR.sub.4 is hydrogen or acyl; when R.sub.4 is acyl, R.sub.1 can also be lower alkyl;And the pharmacologicaly compatible salts thereof; exhibits shown anti-lipolytic, anti-hyperlipaemic and anti-hypercholesterolaemic action.

    摘要翻译: 新的N(6) - 二取代的腺苷化合物,式WHERE R1是被羟基,烷氧基或酰氧基中的至少一个取代的低级烷基; 或是环烷基或直链或支链低级链烯基; R2和R3是氢,卤素或硝基或低级烷基,烷氧基或烷硫基,R4是氢或酰基; 当R 4是酰基时,R 1也可以是低级烷基; 及其药理学兼容性; 展示了抗脂肪,抗高血压和抗高血脂药物作用。

    Quinoxalinyloxy-amino-propanol compounds with blood pressure lowering
and .beta.-blocking properties, their use and pharmaceutical
compositions containing them
    8.
    发明授权
    Quinoxalinyloxy-amino-propanol compounds with blood pressure lowering and .beta.-blocking properties, their use and pharmaceutical compositions containing them 失效
    具有降血压和β-阻断性能的喹喔啉氧基 - 氨基 - 丙醇化合物,它们的用途和含有它们的药物组合物

    公开(公告)号:US4438116A

    公开(公告)日:1984-03-20

    申请号:US302894

    申请日:1981-09-16

    摘要: An aminopropanol compound of the formula ##STR1## wherein R.sub.1 and R.sub.2 are individually selected from hydrogen and lower alkyl; orR.sub.1 and R.sub.2 together represent an alkylene radical;R.sub.3 is hydrogen or acyl;A is one of the following structures ##STR2## wherein R.sub.4 is hydrogen or lower alkyl optionally substituted by hydroxyl halogen and lower alkylthio; andR.sub.5 and R.sub.6 are individually selected from lower alkyl;B is alkylamino which optionally carries a phenyl and a phenoxy radical optionally substituted by at at least one of halogen, hydroxyl or lower alkyl, lower acyl, lower alkylthio, acylamino, aminocarbonyl, lower alkoxy, lower alkenyloxy, phenoxy, lower alkenyl, lower alkylsulphonyl, lower alkylsulphinyl or haloalkyl; orB is an aryl- or heteroaryloxymethylpiperidine radical optionally substituted by at least one of halogen hydroxyl or lower alkyl, hydroxyl alkyl or carboxamido alkyl, or by lower alkoxy, lower acyl, amino, carboxamido, lower alkylcarbonylamido or lower alkylsulphonylamino;and the pharmacologically acceptable salts thereof, are outstandingly effective beta blockers and blood-pressure depressants.

    摘要翻译: 式IMAMA的氨基丙醇化合物,其中R 1和R 2分别选自氢和低级烷基; 或者R 1和R 2一起表示亚烷基; R3是氢或酰基; A是下列结构之一,其中R4是氢或任选被羟基卤素和低级烷硫基取代的低级烷基; 并且R 5和R 6分别选自低级烷基; B是烷基氨基,其任选地带有苯基和苯氧基,其任选被至少一个卤素,羟基或低级烷基,低级酰基,低级烷硫基,酰氨基,氨基羰基,低级烷氧基,低级烯氧基,苯氧基,低级烯基,低级烷基磺酰基 ,低级烷基亚磺酰基或卤代烷基; 或B是任选被卤素羟基或低级烷基,羟基烷基或甲酰胺基烷基中的至少一个取代的芳基或杂芳氧基甲基哌啶基,或由低级烷氧基,低级酰基,氨基,甲酰氨基,低级烷基羰基酰氨基或低级烷基磺酰基氨基取代; 和其药理学上可接受的盐是显着有效的β受体阻滞剂和降压药。